Literature DB >> 21506057

Management of myocardial dysfunction in severe sepsis.

Mathieu Jozwiak1, Romain Persichini, Xavier Monnet, Jean-Louis Teboul.   

Abstract

Sepsis-induced cardiac dysfunction is a frequent and severe complication of septic shock. The mechanisms responsible for its development are complex and intricate. Echocardiography is the best method to make the diagnosis of cardiac dysfunction. Biomarkers (B-type natriuretic peptides and cardiac troponins) can alert clinicians of the possibility of cardiac dysfunction. Low plasma levels can serve to rule out a severe cardiac dysfunction. By contrast, high levels should prompt the performance of an echocardiographic examination. The transpulmonary thermodilution monitor and the pulmonary artery catheter can also be used to alert clinicians or to monitor the effects of inotropic therapy. Dobutamine is the first-line therapy. Its administration remains a matter of debate and should be carefully monitored in terms of efficacy and tolerance. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21506057     DOI: 10.1055/s-0031-1275533

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  11 in total

1.  Stress-related cardiomyopathies.

Authors:  Christian Richard
Journal:  Ann Intensive Care       Date:  2011-09-20       Impact factor: 6.925

2.  When sepsis affects the heart: A case report and literature review.

Authors:  Giuseppe Clemente; Antonino Tuttolomondo; Daniela Colomba; Rosaria Pecoraro; Chiara Renda; Vittoriano Della Corte; Carlo Maida; Irene Simonetta; Antonio Pinto
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

3.  Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.

Authors:  Zenggeng Wang; Qinghua Wu; Xiangbi Nie; Jinghua Guo; Chunli Yang
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

Review 4.  [Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy].

Authors:  L Martin; M Derwall; C Thiemermann; T Schürholz
Journal:  Anaesthesist       Date:  2017-07       Impact factor: 1.041

5.  Global end-diastolic volume increases to maintain fluid responsiveness in sepsis-induced systolic dysfunction.

Authors:  Ronald J Trof; Ibrahim Danad; Ab Johan Groeneveld
Journal:  BMC Anesthesiol       Date:  2013-06-22       Impact factor: 2.217

Review 6.  The Use of Pulmonary Artery Catheter in Sepsis Patients: A Literature Review.

Authors:  Dimitrios Velissaris; Vasilios Karamouzos; Ioanna Kotroni; Charalampos Pierrakos; Menelaos Karanikolas
Journal:  J Clin Med Res       Date:  2016-09-29

7.  A Retrospective Observational Study of the Association Between Plasma Levels of Interleukin 8 in 42 Patients with Sepsis-Induced Myocardial Dysfunction at a Single Center Between 2017 and 2020.

Authors:  XiaoYing Chen; Xian Liu; RuiAn Dong; Dan Zhang; Shu Qin
Journal:  Med Sci Monit       Date:  2021-12-01

8.  Clinical significance of plasma levels of brain natriuretic peptide and cardiac troponin T in patients with sepsis.

Authors:  Jifeng Wang; Wenli Ji; Zhengqin Xu; Tao Pan
Journal:  Exp Ther Med       Date:  2015-11-12       Impact factor: 2.447

9.  Effect of Troponin I Elevation on Duration of Mechanical Ventilation and Length of Intensive Care Unit Stay in Patients With Sepsis.

Authors:  Mohammed Abdalla; Sumit Sohal; Baha'a Al-Azzam; Wiam Mohamed
Journal:  J Clin Med Res       Date:  2019-01-05

Review 10.  The Main Causes and Mechanisms of Increase in Cardiac Troponin Concentrations Other Than Acute Myocardial Infarction (Part 1): Physical Exertion, Inflammatory Heart Disease, Pulmonary Embolism, Renal Failure, Sepsis.

Authors:  Aleksey Chauin
Journal:  Vasc Health Risk Manag       Date:  2021-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.